Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs

Intracranial haemorrhage (ICH) risk after minor traumatic brain injury (mTBI) in patients on antithrombotic treatment is unclear. We compared ICH rates in mTBI patients on single, double and no antithrombotic therapy. Antithrombotic drugs encompassed vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs) and antiplatelets. Secondary aim was to identify potential predictors of ICH.

Source: Thrombosis Research - December 13, 2018 Category: Hematology Authors: S. Galliazzo, M.D. Bianchi, A. Virano, A. Trucchi, M.P. Donadini, F. Dentali, L. Bert ù, A.M. Grandi, W. Ageno Tags: Full Length Article Source Type: research